Literature DB >> 27118752

Nadroparin-induced skin necrosis: clinical manifestation of HIT-2 even in the absence of thrombocytopaenia.

Diego Luis Carrillo Pérez1, Adriana Guadalupe Peña-Romero2, José Manuel Díaz-González2, Judith Domínguez-Cherit2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27118752      PMCID： PMC4854145          DOI： 10.1136/bcr-2016-215288

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study.

Authors:  Theodore E Warkentin; Robin S Roberts; Jack Hirsh; John G Kelton
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

2.  Heparin-induced skin necrosis: HIT-2 without thrombocytopenia.

Authors:  Pierre-Marie Bertrand; Sébastien Perbet; Anne-Françoise Sapin; Magali Salavert; Jean-Michel Constantin; Ismail Elalamy; Jean-Etienne Bazin
Journal:  Intensive Care Med       Date:  2010-09-15       Impact factor: 17.440

3.  Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia.

Authors:  U J Tietge; H H Schmidt; E Jäckel; C Trautwein; M P Manns
Journal:  J Intern Med       Date:  1998-04       Impact factor: 8.989
  3 in total
  1 in total

1.  Rare complication of nadroparin injections: Skin necrosis and heparin-induced thrombocytopenia syndrome.

Authors:  Laura Malinauskiene; Laima Aleksandraviciute; Lina Kryzauskaite; Ilona Savlan
Journal:  Clin Case Rep       Date:  2022-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.